StonvexLoading…
StonvexStonvexStonvexCore line items from BKNG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $26.92B | $23.74B | $21.36B | $17.09B |
Operating Income | $8.82B | $7.55B | $5.83B | $5.10B |
Net Income | $5.40B | $5.88B | $4.29B | $3.06B |
EPS (Diluted) | $165.57 | $172.69 | $117.40 | $76.35 |
Total Assets | $29.26B | $27.71B | $24.34B | $25.36B |
Total Liabilities | $34.84B | $31.73B | $27.09B | $22.58B |
Cash & Equivalents | $17.20B | $16.16B | $12.11B | $12.22B |
Free Cash Flow OCF − CapEx | $9.09B | $7.89B | $7.00B | $6.19B |
Shares Outstanding | 32.64M | 34.06M | 36.53M | 40.05M |